Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome-insights from a UK center.

Res Pract Thromb Haemost · 2025 · PMC12284493 · PMID 40709222

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendP = .07so close (0.05 < p ≤ 0.1)

Use of antiplatelet therapy showed a trend toward bleeding risk ( P = .07) in univariate analysis.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.